No Data
No Data
Clene to Present at Upcoming May Conferences
SALT LAKE CITY, May 14, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, "Clene") and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage bioph
Clene First Quarter 2024 Earnings: Misses Expectations
Clene(CLNN.US) 10% Shareholder Sells US$10,563.8 in Common Stock
$Clene(CLNN.US)$ 10% Shareholder General Resonance LLC sold 26,000 shares of common stock on Apr 30, May 1, 2024 at an average price of $0.4063 for a total value of $10,563.8.Source: Announcement What
Clene Price Target Maintained With a $7.00/Share by HC Wainwright & Co.
Clene Price Target Maintained With a $7.00/Share by HC Wainwright & Co.
Express News | HC Wainwright & Co. Reiterates Buy on Clene, Maintains $7 Price Target
Clene Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/08/2024 1624.14% HC Wainwright & Co. → $7 Reiterates Buy → Buy 04/17/2024 1624.14% HC Wainwright & Co.
No Data
71873966 : Stocks are pushed by those with the handle via social media to entice retail investors, but the true investors ignore the hype.